Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,25 CAD | +11,11% | +11,11% | +8,70% |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Steven Saviuk
CEO | Chief Executive Officer | 65 | 01-10-86 |
Helen Saviuk
DFI | Director of Finance/CFO | 71 | 29-03-10 |
Guy-Paul Allard
LAW | General Counsel | 56 | 01-01-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael Tinmouth
BRD | Director/Board Member | - | 28-04-04 |
Steven Saviuk
CEO | Chief Executive Officer | 65 | 01-10-86 |
Helen Saviuk
DFI | Director of Finance/CFO | 71 | 29-03-10 |
Marc Bélair
BRD | Director/Board Member | - | 03-04-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 12 661 276 | 4 880 389 ( 38,55 %) | 0 | 38,55 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
VALEO PHARMA INC. 25.72% | 25 372 987 | 25.72% | 1 649 244 $ |
CHITOGENX INC. 10.34% | 5 275 392 | 10.34% | 242 668 $ |
Bedrijfsgegevens
Manitex Capital, Inc.
16667 Hymus Boulevard
H9H 4R9, Kirkland
+
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,70% | 2,32 mln. | |
+40,73% | 739 mld. | |
+32,83% | 598 mld. | |
-6,30% | 353 mld. | |
+15,15% | 318 mld. | |
+4,05% | 285 mld. | |
+15,00% | 240 mld. | |
-5,52% | 206 mld. | |
+6,17% | 164 mld. | |
-0,45% | 162 mld. |